India’s first indigenously developed human papillomavirus (HPV) vaccine will be soon administered to women in near future. The research and development related to vaccines ... Sep 02
Digital biomarker startup Koneksa has raised $45 million in their Series C funding round.... Feb 08
Corporate News Updates; Pharma Feb 3rd 2022... Feb 03
Out of the $130 billion spent on healthcare, 60% is spent on in-patient care across private providers alone. Despite its importance and size, the ... Jan 19
California-based healthcare company, Transcarent, raised $200 million in their Series C fund round by Kinnevik and Human Capital. ... Jan 12
... Nov 03
Latest news updates... Oct 26
Latest pharma updates... Oct 12
Latest Pharma Update... Aug 23
Pneumococcal disease is an infection caused by bacteria called Streptococcus pneumoniae, or pneumococcus.... Jul 17
Pharma News Update July 8... Jul 09
Facts about the Alzheimer's disease... Jul 08
Only PARP Inhibitor to Demonstrate Overall Survival Versus New Hormonal Treatments in BRCA1/2-Mutated Advanced Prostate Cancer... Jun 24
Merck Research Laboratories, is scheduled to participate in a virtual fireside chat at the Guggenheim Biopharma Strategy Series... Jun 19
... Jun 09
Phase 3 Pediatric Studies for V114, Merck’s Investigational... May 22
Another pharma collaboration for the advancement of cancer therapies ... Mar 22
This worldwide exclusive license to Merck KGaA, Darmstadt, Germany for the development and commercialization of Xevinapant ... Mar 03
Lupin & its AET Pharma US Inc. (part of Tiefenbacher Group) received an approval for its ANDA from the USFDA... Feb 17
Royal Philips, a global leader in health technology, today announced a multi-year partnership with Merck, a leading science and technology company, to develop clinical-... Jan 15
Merck announced the U.S. FDA accepted for priority review a Biologics License Application for V114, Merck’s investigational 15-valent pneumococcal conjugate vaccine, for ... Jan 12
The drugs discovery program is for servicing the US$111.2B global Metastatic Cancer market... Dec 31
LYNPARZA has been approved in Japan for the treatment of three types of advanced cancer: ovarian, prostate and pancreatic cancer.... Dec 28
... Dec 26
... Dec 23
-Advertisements-
Tuesday, April 16, 2024
